"Because we are in a health care setting, masks are still required in all facilities. Thank you for helping keep our patients and staff safe."

During the past decade, University of Colorado Cancer Center Department of Hematology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Colorado Cancer Center Department of Hematology" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University of Colorado Cancer Center Department of Hematology" are "B-cell Lymphoma" (1 trials), "Head and Neck Cancer" (1 trials) and "Lymphoma, B-Cell" (1 trials). Many other conditions were trialed in "University of Colorado Cancer Center Department of Hematology" in a lesser frequency.

Most popular intervention types in "University of Colorado Cancer Center Department of Hematology" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "5-FU" (1 trials), "Bevacizumab" (1 trials), "CHOP" (1 trials), "Carboplatin" (1 trials) and "Cisplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Colorado Cancer Center Department of Hematology" are 3 trials for "All" genders.

Currently, there are NaN active trials in "University of Colorado Cancer Center Department of Hematology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in University of Colorado Cancer Center Department of Hematology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Colorado Cancer Center Department of Hematology, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".